• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR; AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR; AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR Back to Search Results
Catalog Number 486101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Abnormal Vaginal Discharge (2123); Injury (2348)
Event Type  Injury  
Manufacturer Narrative
The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: ¿potential adverse reactions are those typically associated with surgically implantable materials, including hematoma, seroma, mucosal or visceral erosion, infection, inflammation, sensitization, dyspareunia, scarification and contraction, fistula formation, extrusion and recurrence of vaginal wall prolapse.Perforations or lacerations of vessels, nerves, bladder, bowel, rectum, or any viscera may occur during needle passage." 2348, 2993, 1888, 2123 = "nl".
 
Event Description
The patient's attorney alleged a deficiency against the device.Per additional information received, the patient has experienced scant, spotting postmenopausal type vaginal bleeding as well as occasional vaginal discharge that seems to be aggravated by sexual activity and vaginal intercourse, urinary frequency associated with urgency, occasional incontinence, fecal urgency and occasional fecal incontinence, mesh exposure, small piece of granulation tissue, irritative type symptom as well with intercourse, mesh erosion, vaginal drainage and discharge, voiding dysfunction, prolapse, urinary tract infections, stress incontinence, 2 or 3 spots on anterior vagina, near cervix, fistula, and vaginal erosion.The patient required additional surgical and non-surgical interventions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR
Type of Device
AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key11073800
MDR Text Key223732306
Report Number1018233-2020-06396
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082571
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/01/2010
Device Catalogue Number486101
Device Lot NumberCVSL0009
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age5 MO
Event Location Hospital
Date Manufacturer Received12/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/09/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient Weight83
-
-